Bispecific and multispecific antibody advances in cancer therapy, explaining the kinds of experimental molecules and why researchers are excited to read more.
Key Takeaways
- View all journals Cancer-fighting drugs called bispecific antibodies are having a moment
- Growing number are making their way into the clinic
- Who developed drugs at pharmaceutical company Roche in Basel